|
1.
|
|
12 p, 3.7 MB |
Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors
/
Kilpeläinen, Athina (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Jiménez-Moyano, Esther (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Blanch-Lombarte, Oscar (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Ouchi, Dan (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Peña, Ruth (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Quirant, Bibiana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez-Caballero, Raúl (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Chamorro, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Blanco Guillermo, Ignacio (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Mateu, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Carrillo, Jorge (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Blanco, Julià (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Brander, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Massanella, Marta (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Prado, Julia G. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
The role of T cells in the control of SARS-CoV-2 infection has been underestimated in favor of neutralizing antibodies. However, cellular immunity is essential for long-term viral control and protection from disease severity. [...]
2022 -  10.3389/fimmu.2022.815041
Frontiers in immunology, Vol. 13 (may 2022)
|
|
|
2.
|
|
9 p, 1.3 MB |
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide : a pilot study
/
Merino Ribas, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Araujo, Ricardo (Universidade Do Porto) ;
Bancu, Ioana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Graterol, Fredzzia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vergara, Andrea (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Bonal, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sampaio-Maia, Benedita (University of Porto) ;
Universitat Autònoma de Barcelona
It has been proved that the gut microbiome is altered in patients with chronic kidney disease. This contributes to chronic inflammation and increases cardiovascular risk and mortality, especially in those undergoing hemodialysis. [...]
2021 - 10.1007/s11255-021-03091-3
International Urology and Nephrology, Vol. 54 (december 2021) , p. 2015-2023
|
|
|
3.
|
|
10 p, 1.1 MB |
Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain : a prospective observational cohort study
/
Tarín-Vicente, Eloy José (Hospital Universitario 12 de Octubre (Madrid)) ;
Alemany, Andrea (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Agud-Dios, Manuel (Hospital Universitario 12 de Octubre (Madrid)) ;
Ubals, Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Suñer, Clara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Antón, Andrés (Hospital Universitari Vall d'Hebron) ;
Arando, Maider (Hospital Universitari Vall d'Hebron) ;
Arroyo-Andrés, Jorge (Hospital Universitario 12 de Octubre (Madrid)) ;
Calderón-Lozano, Lorena (Hospital Universitario 12 de Octubre (Madrid)) ;
Casañ, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cabrera, José Miguel (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Coll, Pep (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Descalzo, Vicente (Hospital Universitari Vall d'Hebron) ;
Folgueira, María Dolores (Hospital Universitario 12 de Octubre (Madrid)) ;
García-Pérez, Jorge N (Hospital Universitari Vall d'Hebron) ;
Gil-Cruz, Elena (Hospital Universitario 12 de Octubre (Madrid)) ;
González-Rodríguez, Borja (Hospital Universitario 12 de Octubre (Madrid)) ;
Gutiérrez-Collar, Christian (Hospital Universitario 12 de Octubre (Madrid)) ;
Hernández-Rodríguez, Águeda (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López-Roa, Paula (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ;
de los Ángeles Meléndez, María (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ;
Montero-Menárguez, Julia (Hospital 12 de Octubre (Madrid)) ;
Muñoz-Gallego, Irene (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ;
Palencia-Pérez, Sara Isabel (Universidad Complutense de Madrid. Departamento de Medicina) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Pérez-Rivilla, Alfredo (Universidad Complutense de Madrid. Departamento de Medicina) ;
Piñana, María (Hospital Universitari Vall d'Hebron) ;
Prat, Nuria (Direcció d'Atenció Primària-Metropolitana Nord (Sabadell, Catalunya)) ;
Ramirez, Aída (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rivero, Ángel (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Rubio-Muñiz, Carmen Alejandra (Hospital Universitario 12 de Octubre (Madrid)) ;
Vall, Martí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Acosta-Velásquez, Kevin Stephen (Radiology Department, Hospital Universitario La Paz, Madrid) ;
Wang, An (Hospital Universitario 12 de Octubre (Madrid)) ;
Galván-Casas, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Marks, Michael (University College London, UK) ;
Ortiz-Romero, Pablo L (Universidad Complutense de Madrid. Departamento de Medicina) ;
Mitjà, Oriol (Universitat de Vic - Universitat Central de Catalunya) ;
Universitat Autònoma de Barcelona
In May, 2022, several European countries reported autochthonous cases of monkeypox, which rapidly spread globally. Early reports suggest atypical presentations. We aimed to investigate clinical and virological characteristics of cases of human monkeypox in Spain. [...]
2022 - 10.1016/S0140-6736(22)01436-2
The Lancet (British), Vol. 400 (august 2022) , p. 661-669
|
|
|
4.
|
|
6 p, 1.3 MB |
A simple new screening tool for diagnosing imported schistosomiasis
/
Roure, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez-Quílez, Olga (Institut Català de la Salut) ;
Vallès, Xavier (Institut Germans Trias i Pujol) ;
Valerio, Lluís (Institut Català de la Salut) ;
Fernandez Rivas, Gema (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rivaya, Belén (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López-Muñoz, Israel (Institut Català de la Salut) ;
Soldevila Langa, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Villanova, Xavier (Institut Català de la Salut) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Pedro-Botet, Maria-Lluïsa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Videla, Sebastián (Hospital Universitari de Bellvitge) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
We sought to test the sensitivity and feasibility of a Schistosoma infection screening process consisting of a scored patient consultation questionnaire and a serological diagnostic test. Prospective cross-sectional study. [...]
2022 - 10.1016/j.puhip.2022.100245
Public Health in Practice, Vol. 3 (march 2022)
|
|
|
5.
|
|
16 p, 7.0 MB |
Probiotic effects on immunity and microbiome in HIV-1 discordant patients
/
Blázquez-Bondia, Carlos (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Parera, Mariona (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Català-Moll, Francesc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Casadellà, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Elizalde-Torrent, Aleix (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Aguiló, Meritxell (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Espadaler Mazo, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santos, José Ramon (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
Some HIV-1 infected patients are unable to completely recover normal CD4+ T-cell (CD4+) counts after achieving HIV-1 suppression with combined Antiretroviral Therapy (cART), hence being classified as immuno-discordant. [...]
2022 - 10.3389/fimmu.2022.1066036
Frontiers in immunology, Vol. 13 (december 2022)
|
|
|
6.
|
|
12 p, 583.7 KB |
Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia
/
Batule, Sol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Soldevila i Madorell, Berta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Figueredo, Carme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Egea Cortés, Laia (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ;
Reyes-Urueña, Juliana (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ;
Casabona-Barbarà, Jordi (Institut Germans Trias i Pujol. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya) ;
Mateu, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
López, Rosa (Institut Català de la Salut) ;
Puig Domingo, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Alonso Pedrol, Núria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Diabetes mellitus (DM) and hyperglycemia are important risk factors for poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19). The aim of the present study was to analyze the factors associated with the composite outcome of the necessity of invasive mechanical ventilation (IMV) or admission to the intensive care unit (ICU) in subjects with severe COVID-19 infection treated with dexamethasone comparing patients with DM vs. [...]
2022 - 10.3389/fendo.2022.1009028
Frontiers in Endocrinology, Vol. 13 (december 2022)
|
|
|
7.
|
|
7 p, 1.1 MB |
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients
/
Rodríguez de la Concepción, María Luisa (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Ainsua-Enrich, Erola (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Reynaga, Esteban (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Avila-Nieto, Carlos (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Santos, Jose Ramón (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Roure, Silvia (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Mateu, Lourdes (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Paredes, Roger (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Puig, Jordi (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Jimenez, Juan Manuel (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Izquierdo Useros, Nuria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Clotet Sala, Bonaventura (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Pedro-Botet, Maria Luisa (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ;
Carrillo, Jorge (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
High-dose of IVIG show immunomodulatory properties that may be useful for controlling the hyperinflammatory status observed in COVID-19 patients. The use of high-dose of intravenous immunoglobulins (IVIGs) as immunomodulators for the treatment of COVID-19-affected individuals has shown promising results. [...]
2021 - 10.26508/lsa.202001009
Life Science Alliance, Vol. 4 (july 2021)
|
|
|
8.
|
|
12 p, 780.3 KB |
Observational cohort study of rilpivirine (RPV) utilization in Europe
/
Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ;
Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ;
De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ;
Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ;
Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ;
Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ;
Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ;
Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ;
Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ;
Kusejko, Katharina (University Hospital Zürich (Switzerland)) ;
Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ;
Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ;
Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ;
Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ;
Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ;
Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ;
Van Eygen, Veerle (Janssen Research & Development) ;
Pai, Helen (Janssen Research & Development) ;
Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ;
Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ;
Harxhi, Arjan (Medical University of Tirana (Albania)) ;
Losso, Marcelo Horacio (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Schmied, Brigitte (Institute of Science and Technology Austria (ISTA)) ;
Karpov, Igor Alexandrovich (Belarusian State Medical University (Minsk)) ;
Vassilenko, Anna (Belarusian State Medical University (Minsk)) ;
Paduto, Dmitriy (Regional AIDS Centre (Svetlogorsk, Bèlgica)) ;
Mitsura, Victor (Gomel State Medical University) ;
Clumeck, Nathan (University Hospital Brussels) ;
De Wit, Stéphane A. (Université Libre de Bruxelles) ;
Delforge, Marc D. (Université Libre de Bruxelles) ;
Hadziosmanovic, Vesnadarjan (Clinical Center University of Sarajevo) ;
Begovac, Josip (University of Zagreb) ;
Machala, Ladislav (Charles University in Prague) ;
Jilich, David (Charles University in Prague) ;
Gerstoft, Jan (IT University of Copenhagen) ;
Torp-Pedersen, Christian (Aalborg Universitet) ;
Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ;
Kronborg, Gitte (University of Copenhagen) ;
Benfield, Thomas (Copenhagen University Hospital Hvidovre) ;
Johansen, IS (Odense University Hospital (Dinamarca)) ;
Ostergaard, Leif (Aarhus University) ;
Wiese, Lothar (Roskilde University) ;
Friis-Moller, Nina (Zealand University Hospital) ;
Nielsen, Lars Norregård (Hillerod Hospital (Hillerod, Dinamarca)) ;
Zilmer, Kai (Kaunas University of Technology) ;
Smidt, Jelena (Kohtla - Jarve Jarve Gümnaasium) ;
Aho, Inka (Helsinki University Central Hospital) ;
Viard, Jean-Paul (Université Paris Cité) ;
Girard, Pierre-Marie (University of Paris-Est) ;
Pradier, Christian (Centre Hospitalier Universitaire de Nice) ;
Fontas, Eric (Centre Hospitalier Universitaire de Nice) ;
Duvivier, Claudine (Hôpital Universitaire Necker) ;
Rockstroh, Jurgen (Universitätsklinikum Bonn) ;
Degen, Olaf (University Medical Center Hamburg) ;
Hoffmann, C. (IPM Study Center) ;
Stellbrink, H.J. (IPM Study Center) ;
Stefan, C. (JW Goethe University Hospital (Frankfurt)) ;
Bogner, Johannes (University Hospital München) ;
Fätkenheuer, Gerd (University of Cologne) ;
Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ;
Sambatakou, Helen (Hippokration General Hospital (Athens)) ;
Paissios, N. (Athens General Hospital "G Gennimatas") ;
Uzdaviniene, V. (Vilnius University Hospital Santariskiu Clinics) ;
Staub, T. (Centre Hospitalier de Luxembourg) ;
Dragas, S. ;
Reiss, P. (University of Amsterdam) ;
Trajanovska, J. (University Clinic for Infectious Diseases & Febrile Conditions (Skopje)) ;
Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ;
Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ;
Bruun, Johan (University Hospital of North Norway) ;
Knysz, B. (WWF Poland) ;
Szetela, Bartosz (Nicolaus Copernicus University) ;
Inglot, Malgorzata (Wroclaw Medical University) ;
Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ;
Flisiak, Robert (Medical University of Bialystok) ;
Grzeszczuk, Anna (Medical University of Bialystok) ;
Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ;
Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ;
Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ;
Beniowski, Marek (Medical University of Silesia in Katowice) ;
Mularska, Elżbieta ;
Jablonowska, Elżbieta (University of Lodz) ;
Kamerys, J. (Poznan University of Medical Sciences) ;
Wojcik, K. (University of Lodz) ;
Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ;
Rozplochowski, Błażej (Poznan University of Medical Sciences) ;
Zagalo, A. (Hospital Santa Maria (Lisboa, Portugal)) ;
Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ;
Oprea, Cris (Joint Institute for Nuclear Research) ;
Yakovlev, A. (Saint Petersburg State University) ;
Trofimora, T. (Novgorod Centre for AIDS (Novgorod)) ;
Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ;
Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ;
Borodulina, Elena (Samara State Medical University) ;
Vdoushkina, Elena (Samara State Medical University) ;
Ranin, Jovan (Klinički centar Srbije) ;
Tomazic, J. (Ljubljana University Medical Centre) ;
Miro, Josep M. (Instituto de Salud Carlos III) ;
Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ;
Martinez, E. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Garcia, F. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ;
Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ;
Mallolas Masferrer, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Callau, Pilar (Universitat de Barcelona) ;
Rojas, J. (Hospital Clínic i Provincial de Barcelona) ;
Moreno, Santiago (Pontifical Catholic University of Argentina) ;
del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ;
Jou, A. (IrsiCaixa Institute for AIDS Research) ;
Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Puig, Jordi (Universitat Autònoma de Barcelona) ;
Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Gutierrez, M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sambeat, A. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Laporte, J.M. (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Sonnerborg, A. (Karolinska University Hospital) ;
Flamholc, L. (Skåne University Hospital (Suècia)) ;
Kusejko, Katharina (University of Zurich) ;
Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ;
Calmy, Alexandra (University of Geneva) ;
Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ;
Battegay, Manuel (University of Basel) ;
Schmid, P. (Cantonal Hospital of Schwyz) ;
Kuznetsova, A. (Kyiv National Economic University) ;
Mikhalik, Julia (Crimean Republican AIDS centre) ;
Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ;
Milinkovic, Ana (Imperial College London) ;
Johnson, A.M. (Mortimer Market Centre) ;
Simons, Edwards (Mortimer Market Centre) ;
Edwards, S. (Brookhaven National Laboratory) ;
Phillips, A.M. (Royal Free and University College Medical School) ;
Johnson, M.A. (Royal Free and University College Medical School) ;
Mocroft, A. (Royal Free and University College Medical School) ;
Orkin, Chloe (Queen Mary, University of London) ;
Winston, Alan (Imperial College London) ;
Clarke, A. (University of Sussex) ;
Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 - 10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38
|
|
|
9.
|
|
8 p, 1.0 MB |
Plitidepsin in adult patients with COVID-19 requiring hospital admission : A long-term follow-up analysis
/
Varona, Jose F. (Universidad San Pablo-Centro de Estudios Universitarios (CEU)) ;
Landete, Pedro (Universidad Autónoma de Madrid) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Vates, Roberto (Hospital Universitario de Getafe (Madrid)) ;
Torralba, Miguel (Universidad de Alcalá) ;
Guisado-Vasco, Pablo (Universidad Europea de Madrid) ;
Porras, Lourdes (Hospital General de Ciudad Real) ;
Muñoz, Patricia (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Gijon, Paloma (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Ancochea, Julio (Universidad Autónoma de Madrid) ;
Saiz, Elena (Virology Unit, PharmaMar, SA) ;
Meira, Fernanda (PharmaMar, SA) ;
Jimeno, Jose M. (PharmaMar, SA) ;
Lopez-Martin, Jose A. (PharmaMar, SA) ;
Estrada, Vicente (Universidad Complutense de Madrid) ;
Universitat Autònoma de Barcelona
The APLICOV-PC study assessed the safety and preliminary efficacy of plitidepsin in hospitalized adult patients with COVID-19. In this follow-up study (E-APLICOV), the incidence of post-COVID-19 morbidity was evaluated and any long-term complications were characterized. [...]
2023 - 10.3389/fcimb.2023.1097809
Frontiers in cellular and infection microbiology, Vol. 13 (february 2023)
|
|
|
10.
|
|
9 p, 1.6 MB |
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota
/
Borgognone, Alessandra (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Elizalde-Torrent, Aleix (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Casadellà, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Romero, Luis (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Escribà, Tuixent (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Parera, Mariona (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Català-Moll, Francesc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Brander, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Olvera, Alex (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Paredes, Roger (Universitat Autònoma de Barcelona. Departament de Medicina)
The gut microbiota is emerging as a crucial factor modulating vaccine responses; however, few studies have investigated if vaccines, in turn, can alter the microbiota and to what extent such changes may improve vaccine efficacy. [...]
2022 - 10.1038/s41522-022-00368-y
npj biofilms and microbiomes, Vol. 8 (december 2022)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
